StarZero All shows Try the podcast clipper →

Benchling

4 statements across 1 episodes · 2 bullish · 0 bearish · 1 people on the record · first statement Feb 3, 2017 by Sajith Wickramasekara · said 15 times in 1 episodes since 2017 · across every show →

Mentions by year

brought up most by Sajith Wickramasekara (15)

tap a year for its mentions
00811512017episodesmentions
0112017episodes it came up in
007.50.51512017episodesmentions per episode
2017 15 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about Benchling, oldest first

Feb 3, 2017 positive
Insight
Wickramasekara: Applying standard data practices to life sciences requires little domain expertise
“Using quite standard data practices we were able to make a big dent in a really high impact field that touches everyone and it doesn't require a ton of domain expertise.”
Sajith Wickramasekara Feb 3, 2017 ▶ 12:51 Drug Discovery as a Data Problem // Sajith Wickramasekara, Benchling (FirstMark's Data Driven)
Feb 3, 2017 neutral
Assertion Not checkable as stated
Wickramasekara: Most Benchling employees have no background in life science
“Most of our team actually has no background in the live science at all.”
Sajith Wickramasekara Feb 3, 2017 ▶ 13:05 Drug Discovery as a Data Problem // Sajith Wickramasekara, Benchling (FirstMark's Data Driven)
Feb 3, 2017
Assertion Partly supported
Wickramasekara: Antibody drug discovery begins with tens of thousands of candidates
“Creating something like Avastin actually involves starting with tens of thousands of candidate antibodies in the beginning.”
Sajith Wickramasekara Feb 3, 2017 ▶ 4:04 Drug Discovery as a Data Problem // Sajith Wickramasekara, Benchling (FirstMark's Data Driven)
Feb 3, 2017 positive
Disclosure
Wickramasekara: Benchling adoption spread bottom-up from grad school to pharma giants
“It started with the younger folks. It started with folks in grad school who are going to adopt a tool out of their own volition just because it makes their lives better, and you go to the small biotechs, medium biotechs, and eventually the large companies, the…”
Sajith Wickramasekara Feb 3, 2017 ▶ 14:25 Drug Discovery as a Data Problem // Sajith Wickramasekara, Benchling (FirstMark's Data Driven)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 400 conversations transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more